Biopharmaceutical company PAION AG will present two scientific abstracts on Remimazolam as a short acting sedative at the Anesthesiology 2014 Annual Meeting and American College of Gastroenterology Annual Scientific Meeting.
GI & Endoscopy
Last week, biopharmaceutical company Gilead Sciences travelled to Capitol Hill to brief members of Congress on the cost of its hepatitis C drug Sovaldi, according to a Jewish Times report.
Here are 10 things to know about gastroenterologists and GI/endoscopy procedures performed in the United States.
EMR systems are not one-size-fits all. Modernizing Medicine has created a number of specialty-specific EMR platforms, including EMA GastroenterologyTM. Julie Servoss, MD, Medical Director of GI for Modernizing Medicine, explains why a system designed specifically for the field of GI…
Salix Pharmaceuticals, a developer of medical devices and drugs for the prevention and treatment of gastrointestinal disorders, may be acquired for $190 per share, according to a Triangle Business Journal report.
Advertisement
ColoMarker, a blood test for the early detection of colorectal cancer, has received CE Mark approval.
Physicians undergo rigorous training, from earning their medical degree through fellowship completion, to master clinical skills, but to remain successful in today's challenging environment physicians are beginning to look to an additional skill set: business leadership.
Cantel Medical, a medical equipment company, reported 5 percent growth in profit for its fourth quarter, according to a RTT News report.
The Society of American Gastrointestinal and Endoscopic Surgeons has launched a new program designed to promote safe use of energy-based devices in the endoscopy suite and operating room, according to an EndoNurse report.
Gilead Sciences' hepatitis C treatment Sovaldi, sold at roughly $1,000 per pill, has made headlines for both its price tag and effectiveness. But, the drugs record sales may now be on the decline, according to a Medscape report.